SENEX BIOTECHNOLOGY
Senex Biotechnology, Inc. engages in discovering and developing therapeutic agents to treat cancer, viral diseases, and age-related diseases. The company offers SNX2 non-cytotoxic molecules compounds that are developed against viral diseases, age-associated diseases, and as add-ons to existing anticancer drug regimens; and SNX9 cyclin-dependent kinase inhibitor pathway inhibitors that are developed for cancer treatment. It offers therapeutic agents to treat cancer and a range of diseases associated with the aging process, such as Alzheimer’s disease, renal disease, atherosclerosis, and arthritis. The company was incorporated in 2002 and is based in Columbia, South Carolina.
SENEX BIOTECHNOLOGY
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2002-01-01
Address:
Columbia, South Carolina, United States
Country:
United States
Website Url:
http://www.senexbio.com
Total Employee:
11+
Status:
Active
Contact:
803-777-6161
Email Addresses:
[email protected]
Total Funding:
600 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Gravatar Profiles WordPress Grid Wordpress OEmbed
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.senexbio.com
- Host name: 192.0.78.24
- IP address: 192.0.78.24
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110
More informations about "Senex Biotechnology"
Making Cancers Curable
Senex Biotechnology is a drug discovery and development company focused on cancer therapeutics. Senex’s lead program targets a protein that regulates gene expression and is required by cancer cells to adapt to adversarial conditions; …See details»
Our Company - Senex Bio
Senex Biotechnology was founded by Dr. Igor Roninson, based on the discovery in his academic laboratory of a novel biological pathway associated with aging (senescence) and involved in cancer and other chronic diseases as well as …See details»
Senex Biotechnology - Crunchbase Company Profile
Aug 8, 2013 Senex Biotechnology, Inc. engages in discovering and developing therapeutic agents to treat cancer, viral diseases, and age-related diseases. The company offers SNX2 non-cytotoxic molecules compounds that are developed …See details»
Our Team - Senex Bio
Management Team Igor B Roninson PhD, Founder, President, Chief Scientific Officer and Chairman of the Board. Dennis Goldberg PhD, Chief Executive Officer, Director. George Wilding, MD, Chief Medical Officer. Mengqian (Max) …See details»
Senex Biotechnology Company Profile 2024: Valuation, …
Senex Biotechnology General Information Description. Operator of a drug discovery and development company intended to focus on cancer therapeutics. The company's therapeutic drugs are used to treat cancer, viral diseases and …See details»
Senex Biotechnology Company Profile | Management and
Www.senexbio.com . Senex Biotechnology Profile and History. Senex Biotechnology is a drug discovery and development company focused on oncology therapeutics. Senex was founded …See details»
Senex Biotechnology. Inc. | LinkedIn
Senex is a clinical stage company focused on preventing transcriptional reprogramming, a process by which cancer cells modify gene expression to adapt to adversarial conditions; such …See details»
Senex Biotechnology - Overview, News & Similar companies
Nov 6, 2017 Senex Biotechnology contact info: Phone number: (803) 777-6161 Website: www.senexbio.com What does Senex Biotechnology do? Senex Biotechnology is a drug …See details»
Senex Biotechnology | BioPharm America - Informa Connect
Company/Organization Description or Summary . Senex Biotechnology is a drug discovery and development company focused on preventing the transcriptional reprogramming that allows …See details»
Senex Biotechnology, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Senex Biotechnology, Inc. of Columbia, SC. Get the latest business insights from Dun & Bradstreet.See details»
Senex Biotechnology - Products, Competitors, Financials, …
For further information, visit www.senexbio.com . Contact information: Apr 19, 2022. SCRA Announces Academic Grant Matches. Nov 7, 2017. SCRA Announces Academic Grant …See details»
Senex Biotechnology Information - RocketReach
Senex is a clinical stage company focused on preventing transcriptional reprogramming, a process by which cancer cells modify gene expression to adapt to adversarial conditions; such …See details»
Senex Biotechnology Inc Overview - Salary.com
Discover essential details about Senex Biotechnology Inc, including address, contact, and journey of our company's evolution.See details»
Senex Biotechnology - Employees, Contact info, Overview - Wiza
Apr 30, 2024 View info about Senex Biotechnology (senexbio.com). Senex Biotechnology is a company located in Columbia, SC, United States. Find employees, official website, emails, …See details»
About Us - Senex Bio
Visit the post for more. Already have a WordPress.com account? Log in now.See details»
How much do Senex Biotechnology Inc employees make?
The average annual salary of Senex Biotechnology Inc is estimated to be approximate $87,137 per year. The majority pay is between $76,763 to $98,405 per year. Visit Salary.com to find …See details»
Senex Publication Reveals Importance of CDK8/19 Inhibition as
Nov 18, 2024 [email protected]. Dennis I Goldberg Senex Biotechnology, Inc. +1 508-878-7589 [email protected] Visit us on social media: LinkedIn. Legal Disclaimer:See details»
Senex Publication Reveals Importance of CDK8/19 Inhibition as …
Nov 18, 2024 [email protected]. Dennis I Goldberg Senex Biotechnology, Inc. +1 508-878-7589 [email protected] Visit us on social media: LinkedIn. Legal Disclaimer: EIN …See details»
News and Developments - Senex Bio
November, 2024: Senex scientists and collaborators published a key paper, “Mediator kinase inhibitors suppress triple-negative breast cancer growth and extend tumor suppression by …See details»
Key Publications - Senex Bio
Mediator kinase plays a key role in transcriptional reprogrammingM. Chen et al. Proc. Natl. Acad. Sci. USA 114, 10208-10213 (2017) Both CDK8 and CDK19 Mediator kinases regulate …See details»